Caliway Biopharmaceuticals Co., Ltd. announced a oversubscribed private placement that it has issued 8,000,000 new shares at a price of $12.5 per share for the gross proceeds of $100 million on December 16, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
431.5 TWD | +3.35% | +2.62% | +125.62% |
1st Jan change | Capi. | |
---|---|---|
+125.62% | 1.8B | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- 6919 Stock
- News Caliway Biopharmaceuticals Co., Ltd.
- Caliway Biopharmaceuticals Co., Ltd. announced that it has received $100 million in funding